| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/23/2003 | US20030018180 Secreted protein HFEAF41 |
| 01/23/2003 | US20030018178 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/23/2003 | US20030018168 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030018007 Compositions and methods for inducing gene expression |
| 01/23/2003 | US20030017991 Substrates and assays for beta-secretase activity |
| 01/23/2003 | US20030017982 Genetic engineering; hybrid nucleic acids |
| 01/23/2003 | US20030017981 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017969 Methods and pharmaceutical compositions for healing wounds |
| 01/23/2003 | US20030017967 Insecticides; microbiocides; for plants, seeds |
| 01/23/2003 | US20030017617 Mammalian receptor proteins; related reagents and methods |
| 01/23/2003 | US20030017600 Double selection vector |
| 01/23/2003 | US20030017595 Cells for use as transformation and vector propagation tools in genetic engineering |
| 01/23/2003 | US20030017591 Amplification of prferential nucleotide sequences; obtain nucleotide sequences, denature, incubate with primer and polymerase, amplify, recover nucleotide sequences |
| 01/23/2003 | US20030017590 Propagation of neuronal cells; prepare nutrient broth, inoculate with cell, propagate, recover cells |
| 01/23/2003 | US20030017589 Culturing preferential cells; generate nutrient broth, inoculate with cells, propagate cells, recover cells |
| 01/23/2003 | US20030017588 Nutrient broth for use in the propagation of human cells |
| 01/23/2003 | US20030017587 Embryonic stem cells, clinical applications and methods for expanding in vitro |
| 01/23/2003 | US20030017586 Nucleotide sequences coding polypeptide for use in the treatment of viral diseases |
| 01/23/2003 | US20030017585 Polypeptide for use in the treatment of cancer, nervous system and autoimmune disorders |
| 01/23/2003 | US20030017577 Aparatus for monitoring the activity of inectious nematodes |
| 01/23/2003 | US20030017571 Polynucleotide compositions encoding broad spectrum delta-endotoxins |
| 01/23/2003 | US20030017570 Chitinase materials and methods |
| 01/23/2003 | US20030017564 Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiogenesis |
| 01/23/2003 | US20030017563 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017562 Nucleotide sequences coding polypetide for use in the treatment, prevention and diagnosis of gastrointestinal and apoptosis disorders |
| 01/23/2003 | US20030017548 Proteins for use in treatment of gastrointestinal disorders |
| 01/23/2003 | US20030017547 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 01/23/2003 | US20030017538 Genetically engineered protein for use as diagnostic tool in gentic analysis |
| 01/23/2003 | US20030017537 Amplified genetic expression of genetically engineered hemoglobin; obtain cell, transform with vector coding genetically engineered hemoglobin, express vector, recover hemoglobin |
| 01/23/2003 | US20030017535 Nucleotide sequences coding polypeptide for use in the prevention and treatment of atherosclerosis, cardiovascular and cancerous disorders |
| 01/23/2003 | US20030017533 Slo2 and Slo4, novel potassium channel proteins from human brain |
| 01/23/2003 | US20030017532 ndp |
| 01/23/2003 | US20030017527 Human vanilloid receptor-like proteins |
| 01/23/2003 | US20030017512 Angiostatin receptor |
| 01/23/2003 | US20030017510 Apparatus for use in cell transplantation |
| 01/23/2003 | US20030017504 Antibodies specific for poly(ethylene glycol) |
| 01/23/2003 | US20030017498 Nucleotide sequences coding polypeptides for use as tools in pharmacology, diagnostics, biosensors and bioreactors |
| 01/23/2003 | US20030017495 Enterococcus faecalis polynucleotides and polypeptides |
| 01/23/2003 | US20030017494 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/23/2003 | US20030017479 Methods for the detection, treatment, and prevention of neurodegeneration |
| 01/23/2003 | US20030017478 Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2003 | US20030017476 Nucleotide sequence coding polypeptide for use in the treatment and diagnosis of nervous system disorders |
| 01/23/2003 | US20030017463 Nucleotide sequence coding polypeptide for use in the treatment of heart, cancer and skin disorders |
| 01/23/2003 | US20030017444 Vacuum-mediated desiccation protection of cells |
| 01/23/2003 | US20030017162 Preventing and treating Gram-negative sepsis. |
| 01/23/2003 | US20030017161 Polypeptides that are capable of modulating apoptosis; also Apo-2 chimeras, nucleic acid encoding Apo-2, and antibodies to Apo-2 |
| 01/23/2003 | US20030017160 Human checkpoint kinase, hCDS1, compositions and methods |
| 01/23/2003 | US20030017157 Endothelial cell expression patterns |
| 01/23/2003 | US20030017153 Determining whether a patient's immune system can be modified through stimulation of thymus function; sex steroids are ablated in the patient, and the resulting production of thymic factors is monitored. |
| 01/23/2003 | US20030017152 Administering a substance that specifically depletes alpha beta -, and gamma delta -TCR+ T cells and/or CD8+ T cells, followed by transplantation with a donor cell preparation containing hematopoietic stem cells from a matched donor |
| 01/23/2003 | US20030017150 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 01/23/2003 | US20030017147 Novel alpha-2-antiplasmin- binding molecules and treatment for pulmonary embolism, myocardial infarction, thrombosis or stroke in a patient |
| 01/23/2003 | US20030017143 Reduction of risk of rejection of allografts and xenografts and autoimmune diseases using the human suppressor CD8+CD28- T cells |
| 01/23/2003 | US20030017142 Used to culture cells with transport of oxygen through the membrane (i.e., direct oxygenation), without regard for the flow rate of the liquid medium passing through the device; liver assist systems |
| 01/23/2003 | US20030017141 Treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 01/23/2003 | US20030017138 Chimeric adenoviruses |
| 01/23/2003 | US20030017134 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 01/23/2003 | CA2707767A1 Biologically active peptides |
| 01/23/2003 | CA2453672A1 Root nodule bacteria having enhanced nitrogen-fixation ability |
| 01/23/2003 | CA2453574A1 Transgenic plants expressing cobalamin binding proteins |
| 01/23/2003 | CA2453566A1 Method and composition for inhibiting heparanase activity |
| 01/23/2003 | CA2453531A1 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells |
| 01/23/2003 | CA2453496A1 Survivin interacting protein tpr1 |
| 01/23/2003 | CA2453494A1 Histidine phosphatase interacting protein with 180kd |
| 01/23/2003 | CA2453438A1 Cells of the cardiomyocyte lineage produced from human pluripotent stem cells |
| 01/23/2003 | CA2453436A1 Cryopreservation system with controlled dendritic freezing front velocity |
| 01/23/2003 | CA2453405A1 Pseudotyped adeno-associated viruses and uses thereof |
| 01/23/2003 | CA2453381A1 Methods for ex vivo propagation of somatic stem cells |
| 01/23/2003 | CA2453187A1 Production of transduced hematopoietic progenitor cells |
| 01/23/2003 | CA2453183A1 In vivo production of small interfering rnas that mediate gene silencing |
| 01/23/2003 | CA2453161A1 Lymphatic endothelial cells materials and methods |
| 01/23/2003 | CA2452867A1 Allelic variants of gpr50 |
| 01/23/2003 | CA2452630A1 Use of oxidised lipoproteins for differentiation of precursor cells into mature dendritic cells |
| 01/23/2003 | CA2452619A1 Disposable vessel |
| 01/23/2003 | CA2452517A1 Recombinant vsv for the treatment of tumor cells |
| 01/23/2003 | CA2452417A1 Compositions comprising the biologicially active peptide ysl |
| 01/23/2003 | CA2449411A1 Human cytokine receptor |
| 01/23/2003 | CA2449243A1 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/23/2003 | CA2447585A1 Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit |
| 01/22/2003 | EP1277837A2 Epididymis-specific DNA sequences and their use |
| 01/22/2003 | EP1277762A2 Low allergenic protein variants |
| 01/22/2003 | EP1276907A2 Viral vectors for use in monitoring hiv drug resistance |
| 01/22/2003 | EP1276902A2 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 01/22/2003 | EP1276896A2 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 01/22/2003 | EP1276894A2 Method for screening of microorganisms under nutrient limited conditions |
| 01/22/2003 | EP1276893A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 01/22/2003 | EP1276887A2 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 01/22/2003 | EP1276884A2 Transgenic plants |
| 01/22/2003 | EP1276882A2 Method for genetically modifying a plant |
| 01/22/2003 | EP1276880A2 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications |
| 01/22/2003 | EP1276879A1 MUIR-TORRE-LIKE SYNDROME IN Fhit DEFICIENT MICE |
| 01/22/2003 | EP1276878A2 Reversible immortalization |
| 01/22/2003 | EP1276877A2 Agent for postoperative use after the removal of bone tumours |
| 01/22/2003 | EP1276872A2 A thymus expressed human cytochrome p450 (p450tec) |
| 01/22/2003 | EP1276868A2 Identification of human gaba transporter |
| 01/22/2003 | EP1276866A2 Novel compounds |
| 01/22/2003 | EP1276865A2 Methods for binding an exogenous molecule to cellular chromatin |
| 01/22/2003 | EP1276863A1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 01/22/2003 | EP1276857A1 Signal sequence trapping |
| 01/22/2003 | EP1276856A1 Albumin fusion proteins |